Premium
Gender equity in STEMI : Not so simple!
Author(s) -
Wei Janet,
Henry Timothy D.
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.25800
Subject(s) - medicine , mace , conventional pci , antithrombotic , female sex , angina , cardiology , myocardial infarction
Key Points Women with STEMI undergoing primary PCI have a higher risk of short‐term and long‐term bleeding and MACE compared to men, although increased long‐term MACE is driven by increased female baseline comorbidities and treatment differences. Female sex is an easily identifiable phenotype that should alert clinicians to perform sex‐specific cardiovascular risk assessment for prevention, recognize female‐pattern angina symptoms, and provide education to reduce the delay between symptom onset and hospital presentation. Female sex remains an independent predictor of major bleeding and additional studies are required to determine female‐specific antithrombotic regimens and catheter‐access protocols.